Negotiating Partnerships in the Healthcare Industry (B): The Pharmac and Respire Deal Description
This case has been developed to facilitate a negotiation exercise related to the formation of partnership deals in the healthcare industry. It is based on actual information, but reflects a hypothetical situation involving two companies and a product that have all been disguised. The scenario described within the case involves Pharmac, a large pharmaceutical company, and Respire, a small medical start-up. Pharmac and Respire began negotiating a partnership to develop and eventually market an inhaled form of parathyroid hormone (PTH) to treat osteoporosis. If successful, this product would improve the available options for the treatment of osteoporosis. It was also expected to produce "blockbuster" sales since it would make PTH, an already extremely effective treatment option, more convenient and appealing to a large segment of untreated patients who were injection-averse (injection was the standard delivery mechanism for this drug). Development of the product was highly speculative and was expected to take six to seven years due to early stage development of the inhalable delivery system and the multi-year Phase III fracture trials required for approval. Pharmac had released the first man-made, injectable form of parathyroid hormone, called Strocal, in 2002. However, no one had yet developed a non-injectable version of PTH, despite efforts by Pharmac and other companies that spanned more than a decade. Respire's goal was to be the first company to solve this problem by developing an inhaled formulation and a device to deliver Strocal through the lungs in a safe, effective, and reproducible manner. Enough information is provided within the case to enable students to negotiate terms for royalties, milestones, exclusivity provisions, and an equity investment. At the end of OIT-81A, information known to Pharmac (but not to Respire) is provided. In OIT-81B, information known to Respire (but not to Pharmac) is given.
100% money back guarantee if the quality doesn't match the promise
100% Plagiarism Free
If the work we produce contain plagiarism then we payback 1000 USD
Paypal Secure
All your payments are secure with Paypal security.
300 Words per Page
We provide 300 words per page unlike competitors' 250 or 275
Freebies
Free Title Page, Citation Page, References, Exhibits, Revision, Charts
Case study solutions are career defining. Order your custom solution now.
Case Analysis of Negotiating Partnerships in the Healthcare Industry (B): The Pharmac and Respire Deal
Negotiating Partnerships in the Healthcare Industry (B): The Pharmac and Respire Deal is a Harvard Business (HBR) Case Study on Leadership & Managing People , Texas Business School provides HBR case study assignment help for just $9. Texas Business School(TBS) case study solution is based on HBR Case Study Method framework, TBS expertise & global insights. Negotiating Partnerships in the Healthcare Industry (B): The Pharmac and Respire Deal is designed and drafted in a manner to allow the HBR case study reader to analyze a real-world problem by putting reader into the position of the decision maker. Negotiating Partnerships in the Healthcare Industry (B): The Pharmac and Respire Deal case study will help professionals, MBA, EMBA, and leaders to develop a broad and clear understanding of casecategory challenges. Negotiating Partnerships in the Healthcare Industry (B): The Pharmac and Respire Deal will also provide insight into areas such as – wordlist , strategy, leadership, sales and marketing, and negotiations.
Case Study Solutions Background Work
Negotiating Partnerships in the Healthcare Industry (B): The Pharmac and Respire Deal
case study solution
is focused on solving the strategic and operational challenges the protagonist of the case is facing. The challenges involve – evaluation of strategic options, key role of Leadership & Managing People, leadership qualities of the protagonist, and dynamics of the external environment. The challenge in front of the protagonist, of Negotiating Partnerships in the Healthcare Industry (B): The Pharmac and Respire Deal, is to not only build a competitive position of the organization but also to sustain it over a period of time.
Strategic Management Tools Used in Case Study Solution
The Negotiating Partnerships in the Healthcare Industry (B): The Pharmac and Respire Deal case study solution requires the MBA, EMBA, executive, professional to have a deep understanding of various strategic management tools such as SWOT Analysis, PESTEL Analysis / PEST Analysis / STEP Analysis, Porter Five Forces Analysis, Go To Market Strategy, BCG Matrix Analysis, Porter Value Chain Analysis, Ansoff Matrix Analysis, VRIO / VRIN and Marketing Mix Analysis.
Texas Business School Approach to Leadership & Managing People Solutions
In the Texas Business School, Negotiating Partnerships in the Healthcare Industry (B): The Pharmac and Respire Deal case study solution – following strategic tools are used - SWOT Analysis, PESTEL Analysis / PEST Analysis / STEP Analysis, Porter Five Forces Analysis, Go To Market Strategy, BCG Matrix Analysis, Porter Value Chain Analysis, Ansoff Matrix Analysis, VRIO / VRIN and Marketing Mix Analysis.
We have additionally used the concept of supply chain management and leadership framework to build a comprehensive case study solution for the case – Negotiating Partnerships in the Healthcare Industry (B): The Pharmac and Respire Deal
Step 1 – Problem Identification of Negotiating Partnerships in the Healthcare Industry (B): The Pharmac and Respire Deal - Harvard Business School Case Study
The first step to solve HBR Negotiating Partnerships in the Healthcare Industry (B): The Pharmac and Respire Deal case study solution is to identify the problem present in the case. The problem statement of the case is provided in the beginning of the case where the protagonist is contemplating various options in the face of numerous challenges that Pharmac Respire is facing right now. Even though the problem statement is essentially – “Leadership & Managing People” challenge but it has impacted by others factors such as communication in the organization, uncertainty in the external environment, leadership in Pharmac Respire, style of leadership and organization structure, marketing and sales, organizational behavior, strategy, internal politics, stakeholders priorities and more.
Step 2 – External Environment Analysis
Texas Business School approach of case study analysis – Conclusion, Reasons, Evidences - provides a framework to analyze every HBR case study. It requires conducting robust external environmental analysis to decipher evidences for the reasons presented in the Negotiating Partnerships in the Healthcare Industry (B): The Pharmac and Respire Deal.
The external environment analysis of Negotiating Partnerships in the Healthcare Industry (B): The Pharmac and Respire Deal will ensure that we are keeping a tab on the macro-environment factors that are directly and indirectly impacting the business of the firm.
What is PESTEL Analysis? Briefly Explained
PESTEL stands for political, economic, social, technological, environmental and legal factors that impact the external environment of firm in Negotiating Partnerships in the Healthcare Industry (B): The Pharmac and Respire Deal case study. PESTEL analysis of " Negotiating Partnerships in the Healthcare Industry (B): The Pharmac and Respire Deal" can help us understand why the organization is performing badly, what are the factors in the external environment that are impacting the performance of the organization, and how the organization can either manage or mitigate the impact of these external factors.
How to do PESTEL / PEST / STEP Analysis? What are the components of PESTEL Analysis?
As mentioned above PESTEL Analysis has six elements – political, economic, social, technological, environmental, and legal. All the six elements are explained in context with Negotiating Partnerships in the Healthcare Industry (B): The Pharmac and Respire Deal macro-environment and how it impacts the businesses of the firm.
How to do PESTEL Analysis for Negotiating Partnerships in the Healthcare Industry (B): The Pharmac and Respire Deal
To do comprehensive PESTEL analysis of case study – Negotiating Partnerships in the Healthcare Industry (B): The Pharmac and Respire Deal , we have researched numerous components under the six factors of PESTEL analysis.
Political Factors that Impact Negotiating Partnerships in the Healthcare Industry (B): The Pharmac and Respire Deal
Political factors impact seven key decision making areas – economic environment, socio-cultural environment, rate of innovation & investment in research & development, environmental laws, legal requirements, and acceptance of new technologies.
Policy Making Impact on Negotiating Partnerships in the Healthcare Industry (B): The Pharmac and Respire Deal
Government policies have significant impact on the business environment of any country. The firm in “ Negotiating Partnerships in the Healthcare Industry (B): The Pharmac and Respire Deal ” needs to navigate these policy decisions to create either an edge for itself or reduce the negative impact of the policy as far as possible.
Data safety laws – The countries in which Pharmac Respire is operating, firms are required to store customer data within the premises of the country. Pharmac Respire needs to restructure its IT policies to accommodate these changes. In the EU countries, firms are required to make special provision for privacy issues and other laws.
Competition Regulations – Numerous countries have strong competition laws both regarding the monopoly conditions and day to day fair business practices. Negotiating Partnerships in the Healthcare Industry (B): The Pharmac and Respire Deal has numerous instances where the competition regulations aspects can be scrutinized.
Import restrictions on products – Before entering the new market, Pharmac Respire in case study Negotiating Partnerships in the Healthcare Industry (B): The Pharmac and Respire Deal" should look into the import restrictions that may be present in the prospective market.
Export restrictions on products – Apart from direct product export restrictions in field of technology and agriculture, a number of countries also have capital controls. Pharmac Respire in case study “ Negotiating Partnerships in the Healthcare Industry (B): The Pharmac and Respire Deal ” should look into these export restrictions policies.
Foreign Direct Investment Policies – Government policies favors local companies over international policies, Pharmac Respire in case study “ Negotiating Partnerships in the Healthcare Industry (B): The Pharmac and Respire Deal ” should understand in minute details regarding the Foreign Direct Investment policies of the prospective market.
Taxation & Regulation Impact on Negotiating Partnerships in the Healthcare Industry (B): The Pharmac and Respire Deal
Corporate Taxes – The rate of taxes is often used by governments to lure foreign direct investments or increase domestic investment in a certain sector. Corporate taxation can be divided into two categories – taxes on profits and taxes on operations. Taxes on profits number is important for companies that already have a sustainable business model, while taxes on operations is far more significant for companies that are looking to set up new plants or operations.
Tariffs – Chekout how much tariffs the firm needs to pay in the “ Negotiating Partnerships in the Healthcare Industry (B): The Pharmac and Respire Deal ” case study. The level of tariffs will determine the viability of the business model that the firm is contemplating. If the tariffs are high then it will be extremely difficult to compete with the local competitors. But if the tariffs are between 5-10% then Pharmac Respire can compete against other competitors.
Government Scheme & Subsidies Impact on Negotiating Partnerships in the Healthcare Industry (B): The Pharmac and Respire Deal
Research and Development Subsidies and Policies – Governments often provide tax breaks and other incentives for companies to innovate in various sectors of priority. Managers at Negotiating Partnerships in the Healthcare Industry (B): The Pharmac and Respire Deal case study have to assess whether their business can benefit from such government assistance and subsidies.
Consumer protection – Different countries have different consumer protection laws. Managers need to clarify not only the consumer protection laws in advance but also legal implications if the firm fails to meet any of them.
Political System & Stability, and its Impact on Negotiating Partnerships in the Healthcare Industry (B): The Pharmac and Respire Deal
Political System and Its Implications – Different political systems have different approach to free market and entrepreneurship. Managers need to assess these factors even before entering the market.
Freedom of Press is critical for fair trade and transparency. Countries where freedom of press is not prevalent there are high chances of both political and commercial corruption.
Corruption level – Pharmac Respire needs to assess the level of corruptions both at the official level and at the market level, even before entering a new market. To tackle the menace of corruption – a firm should have a clear SOP that provides managers at each level what to do when they encounter instances of either systematic corruption or bureaucrats looking to take bribes from the firm.
Independence of judiciary – It is critical for fair business practices. If a country doesn’t have independent judiciary then there is no point entry into such a country for business.
Government attitude towards trade unions – Different political systems and government have different attitude towards trade unions and collective bargaining. The firm needs to assess – its comfort dealing with the unions and regulations regarding unions in a given market or industry. If both are on the same page then it makes sense to enter, otherwise it doesn’t.
Economic Factors that Impact Negotiating Partnerships in the Healthcare Industry (B): The Pharmac and Respire Deal
Social Factors that Impact Negotiating Partnerships in the Healthcare Industry (B): The Pharmac and Respire Deal
Technological Factors that Impact Negotiating Partnerships in the Healthcare Industry (B): The Pharmac and Respire Deal
Environmental Factors that Impact Negotiating Partnerships in the Healthcare Industry (B): The Pharmac and Respire Deal
Legal Factors that Impact Negotiating Partnerships in the Healthcare Industry (B): The Pharmac and Respire Deal
Step 3 – Industry Specific Analysis
What is Porter Five Forces Analysis
PESTEL stands for political, economic, social, technological, environmental and legal factors that impact the external environment of firm in Negotiating Partnerships in the Healthcare Industry (B): The Pharmac and Respire Deal case study. PESTEL analysis of " Negotiating Partnerships in the Healthcare Industry (B): The Pharmac and Respire Deal" can help us understand why the organization is performing badly, what are the factors in the external environment that are impacting the performance of the organization, and how the organization can either manage or mitigate the impact of these external factors.
Amanda is strategy expert at Texas Business School. She is passionate about corporate strategy, competitive strategy, game theory, and business model innovation. You can hire Texas Business School professinoals to revolutionize your strategy & business.
Hurley Dry-Fit Chino Short. Men's chino short. Outseam Length: 19 Dri-FIT Technology helps keep you dry and comfortable. Made with sweat-wicking fabric. Fitted waist with belt loops. Button waist with zip fly provides a classic look and feel .
